Presenters
Asif Dhar, MD
Partner, Deloitte Consulting, Deloitte, United States
Asif was an original architect of ConvergeHEALTH by Deloitte and was also the former managing director of Deloitte Health Informatics, LLC. He is also a Chief Medical Informatics Officer for Deloitte Consulting and helps drive our Therapeutic Area Transformation Integrated offering. He is a thought leader on topics such as comparative and clinical effectiveness, exponentials and innovation, personalized medicine, informatics, and disease transformation. He had a leadership role at one of the Nation’s largest HIT corporations and has a deep understanding of the complexities of clinical data reuse for safety, quality, and outcomes.
Angela Dobes, MPH
IBD Plexus Director , Crohn's & Colitis Foundation of America, United States
Angela has more than 10 years of experience in the health care industry and is the IBD Plexus program Director at CCFA. She has previously worked for clinical technology and pharmaceutical organizations, where she has led implementation of various technology solutions focused on accelerating the delivery of new therapies to patients safely. Angela has also conducted research in the fields of managed care and patient engagement and is a member of the CCFA Partners Research Team. She holds an undergraduate degree in Chemical Engineering from Lehigh University and she earned her graduate degree in Public Health from the Icahn School of Medicine at Mount Sinai.
Beth Meagher
Principal, Deloitte Consulting, United States
Beth Meagher is a Deloitte Consulting LLP principal and leader of the Federal Monitor Deloitte Strategy practice. She started and leads Deloitte's Translational Medicine, which bring strategy, informatics, clinical, and research capabilities together on collaborative teams. Beth focuses on helping the Federal government transform how it views customers; leading teams to create impactful ecosystems; and preparing leaders for changes in strategy, policy, and innovation. She has served entities driving research, innovation, and health impact such as the NIH, HHS, and PCORI. She serves on the BioHealth Innovation board.
Have an account?